Drug Profile
Research programme: tacrolimus analogues - Kosan Biosciences
Latest Information Update: 10 Nov 2003
Price :
$50
*
At a glance
- Originator Kosan Biosciences
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Transplant rejection
Most Recent Events
- 10 Nov 2003 This programme is available for licensing (http://www.kosan.com)
- 10 Nov 2003 Discontinued - Preclinical for Transplant rejection in USA (unspecified route)
- 12 Jul 2000 New profile